Skip to main content
All lobbying clients

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Lobbying client · District of Columbia · filed 2025 to 2026

represents biopharmaceutical research companies

$310,000 Reported spend
6 Filings counted
1 Firms hired
20 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (192228), not by name.

 Firms hired 1
 Bills named in these filings 20
  • S 1040
    Drug Competition Enhancement Act
    6 filings
  • S 1041
    Affordable Prescriptions for Patients Act
    6 filings
  • S 1095
    Stop STALLING Act
    6 filings
  • S 1096
    Preserve Access to Affordable Generics and Biosimilars Act
    6 filings
  • S 1097
    Interagency Patent Coordination and Improvement Act of 2025
    6 filings
  • S 527
    Prescription Pricing for the People Act of 2025
    6 filings
  • S 891
    Bipartisan Health Care Act
    6 filings
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    5 filings
  • S 832
    EPIC Act of 2025
    5 filings
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    3 filings
  • HR 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fisc…
    2 filings
  • S 2296
    National Defense Authorization Act for Fiscal Year 2026
    2 filings
  • HCONRES 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…
    1 filing
  • HR 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
    1 filing
  • HR 8646
    Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
    1 filing
  • HR 8800
    National Defense Authorization Act for Fiscal Year 2027
    1 filing
  • HR 9260
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
    1 filing
  • S 2658
    Medication Affordability and Patent Integrity Act
    1 filing
  • S 3014
    Ensuring Timely Access to Generics Act of 2025
    1 filing
  • S 4784
    National Defense Authorization Act for Fiscal Year 2027
    1 filing
 Reported by year 2 years
  • 2026 $100,000 2 filings
  • 2025 $210,000 4 filings
 Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem